Leveraging Transcriptomic Approaches to Support Cell Therapy Characterization and Critical Quality Attribute Identification
1:45 pm - Thursday 3rd December 2026
- Leveraging transcriptomic technologies, including qPCR, bulk RNA sequencing, and single-cell RNA sequencing, to characterize cell therapy products
- Applying transcriptional profiling to evaluate process-related differences, enhance product understanding, and support identification of candidate critical quality attributes
- Translating transcriptomic insights into analytical strategies that strengthen product characterization and support development and lifecycle decision-making
